According to a 🆕 The National Institutes of Health-supported study, most Americans don’t know that primary care physicians can prescribe addiction treatment. The findings, published in JAMA Network Open, reveal a crucial need to increase public awareness that medications for opioid use disorder can be prescribed in primary care settings. National Institute of General Medical Sciences (NIGMS) JCOIN Coordination and Translation Center Brown University #nihHEALinitiative https://go.nih.gov/GIgpGMt
The National Institute on Drug Abuse (NIDA)’s Post
More Relevant Posts
-
Are you or someone you know experiencing a substance use and/or mental health crisis or any other kind of emotional distress? Call or text 988 or go to 988lifeline.org to reach the 988 Suicide & Crisis Lifeline. Trained crisis counselors are available to help you.
-
Researchers: Are you interested in making an impact on SUD-related innovations? Join the July 9th webinar below 👇 to learn more about the #NIDA-funded MIT Biomedical Product Development & Entrepreneurship Program - an immersive hybrid program consisting of live expert webinars, & online courses, culminating in a 5-day Bootcamp at Massachusetts Institute of Technology: https://loom.ly/m0E9Ixo Applications for the program are due soon (July 15): https://loom.ly/r4PHWgk
-
🆕 #NIDA-funded study published in Health Affairs: Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits. University of South Carolina https://loom.ly/w9uTRao
Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits | Health Affairs Journal
healthaffairs.org
-
🗣️📢On 7/22 @ 12 pm ET, #NIDA & Coalition for Global Hepatitis Elimination are hosting a webinar on #hepatitis C in the context of drug use; state-of-the-art diagnostic and pathogenic efforts. Register here & join the conversation: https://loom.ly/RLCyzvY
-
-
NIH #UNITE is hosting a virtual workshop on identifying ways to address the negative impacts of #StructuralRacism on health outcomes and in biomedical and behavioral research. Join us on July 18th - 19th 2024 to discuss Interdisciplinary Approaches to Understanding and Addressing Structural Racism and Health! During this virtual workshop, participants will join breakouts that will collaboratively identify: ▪️ Methodologies and measures for studying structural racism and health disparities ▪️ Consequences of structural racism that affect health ▪️ Strategies for productive cross-disciplinary partnerships ▪️ Interventions to address the impact of structural racism on health Researchers, clinicians, and community partners are welcome! Participants include experts in social and natural sciences, law and criminal justice, education, public policy, and social work, as well as biomedical, behavioral, and public health. Register today: bit.ly/UNITE-2024
-
-
This year, the National Institute on Drug Abuse marks 50 years of scientific achievements in addiction science. NIDA's investment in research, innovation, and drug development has contributed to approvals of new, lifesaving treatments and interventions for substance use and addiction. Learn how decades of research has made an impact on preventing, diagnosing, and treating addiction and its health effects.
-
The National Institutes of Health's National Institute on Drug Abuse is seeking a Physician/Medical Officer who will participate in designing and conducting clinical trials, developing protocols, medical monitoring of clinical trials, providing technical assistance in study design and data analysis, and more. Candidates with experience in conducting clinical trials, medication drug development, working with pharmaceutical industry, FDA, or IRB are encouraged to apply. Learn more and apply: https://lnkd.in/eD8MRcer Applications are due July 3, 2024.
-
-
SAVE THE DATE 🗓️ Oct. 4, 2024 is the NIDA-NIAAA SfN Mini-Convention: Frontiers in Addiction Research in Chicago. Register to join the presentations and discussions of current topics in neuroscience and addiction research: https://loom.ly/raI88mg Society for Neuroscience
-
-
Researchers, check out this The National Institutes of Health Funding Opportunity: Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools to Accelerate Therapeutics Development for Opioid and Stimulant Use Disorders. 📆 Applications due July 9. https://lnkd.in/gbF_nXAd
-
-
Check out this 🆕 commentary from #NIDA Director Dr. Nora Volkow and leaders from Centers for Disease Control and Prevention and Substance Abuse and Mental Health Services Administration (SAMHSA) discussing major gaps in care for opioid use disorder, and implications for clinical practice. JAMA #OUD https://lnkd.in/ejiPFEPT
Major Gaps in the Cascade of Care for Opioid Use Disorder
jamanetwork.com
